Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies.
Andrade-Meza A, Arias-Romero LE, Armas-López L, Ávila-Moreno F, Chirino YI, Delgado-Buenrostro NL, García-Castillo V, Gutiérrez-Cirlos EB, Juárez-Avelar I, Leon-Cabrera S, Mendoza-Rodríguez MG, Olguín JE, Perez-Lopez A, Pérez-Plasencia C, Reyes JL, Sánchez-Pérez Y, Terrazas LI, Vaca-Paniagua F, Villamar-Cruz O, Rodríguez-Sosa M. Andrade-Meza A, et al. Int J Mol Sci. 2023 Jan 20;24(3):2115. doi: 10.3390/ijms24032115. Int J Mol Sci. 2023. PMID: 36768437 Free PMC article. Review.
microRNA-18b is upregulated in breast cancer and modulates genes involved in cell migration.
Fonseca-Sanchéz MA, Pérez-Plasencia C, Fernández-Retana J, Arechaga-Ocampo E, Marchat LA, Rodríguez-Cuevas S, Bautista-Piña V, Arellano-Anaya ZE, Flores-Pérez A, Diaz-Chávez J, López-Camarillo C. Fonseca-Sanchéz MA, et al. Oncol Rep. 2013 Nov;30(5):2399-410. doi: 10.3892/or.2013.2691. Epub 2013 Aug 22. Oncol Rep. 2013. PMID: 23970382
Selective silencing of gene target expression by siRNA expression plasmids in human cervical cancer cells.
Peralta-Zaragoza O, De-la-O-Gómez F, Deas J, Fernández-Tilapa G, Fierros-Zárate Gdel S, Gómez-Cerón C, Burguete-García A, Torres-Poveda K, Bermúdez-Morales VH, Rodríguez-Dorantes M, Pérez-Plasencia C, Madrid-Marina V. Peralta-Zaragoza O, et al. Methods Mol Biol. 2015;1249:153-71. doi: 10.1007/978-1-4939-2013-6_11. Methods Mol Biol. 2015. PMID: 25348304
Targeted treatments for cervical cancer: a review.
Peralta-Zaragoza O, Bermúdez-Morales VH, Pérez-Plasencia C, Salazar-León J, Gómez-Cerón C, Madrid-Marina V. Peralta-Zaragoza O, et al. Onco Targets Ther. 2012;5:315-28. doi: 10.2147/OTT.S25123. Epub 2012 Nov 2. Onco Targets Ther. 2012. PMID: 23144564 Free PMC article.
Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.
Villarreal-Garza C, Alvarez-Gómez RM, Pérez-Plasencia C, Herrera LA, Herzog J, Castillo D, Mohar A, Castro C, Gallardo LN, Gallardo D, Santibáñez M, Blazer KR, Weitzel JN. Villarreal-Garza C, et al. Cancer. 2015 Feb 1;121(3):372-8. doi: 10.1002/cncr.29058. Epub 2014 Sep 18. Cancer. 2015. PMID: 25236687 Free PMC article.
MicroRNA-125 modulates radioresistance through targeting p21 in cervical cancer.
Pedroza-Torres A, Campos-Parra AD, Millan-Catalan O, Loissell-Baltazar YA, Zamudio-Meza H, Cantú de León D, Montalvo-Esquivel G, Isla-Ortiz D, Herrera LA, Ángeles-Zaragoza Ó, Robelo-Romero G, Herrera-Gómez Á, Pérez-Plasencia C. Pedroza-Torres A, et al. Oncol Rep. 2018 Mar;39(3):1532-1540. doi: 10.3892/or.2018.6219. Epub 2018 Jan 18. Oncol Rep. 2018. PMID: 29399698
123 results